Determining infants’ age for measles vaccination based on persistence of protective level of maternal measles antibody

Authors

  • Tanjida Shilpi Department of Microbiology and Immunology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka,
  • Humayun Sattar Department of Microbiology and Immunology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka,
  • Md. Ruhul Amin Miah Department of Microbiology and Immunology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka,

DOI:

https://doi.org/10.3329/bmrcb.v35i3.4204

Keywords:

Infant, Measle, Vaccination

Abstract

The present study was conducted over a period of one year to find the right time for measles vaccination when maternal antibody titer in infants was decayed rendering them susceptible to wild virus infection. Blood samples were collected from the cord of new born (147), 2-5 months (47) and 5 to 7.5 months (24) of age. The mean measles IgG antibody titer detected in cord blood at birth (0 months) was 348.8 mIU/mL which steeply decreased to 155.6 mIU/mL by the age of 2-3 months. After that the fall in antibody becomes relatively slower and decreased to 101.6 mIU/mL by the age of 3-5 months and 38.8 mIU/mL by the age of 5-6 months and to 19.2 mIU/mL between the age of 6 to 7.5 months. The fall in antibody level with the advance of age was statistically significant (p<0.001). Majority of the subjects (97.6%) exhibited protective level of antibody at birth. But only a little above one-quarter (25.5%) of them persisted the protective level between the age of 2-5 months and none had protective level from 5 months onwards.

Keywords: Infant; Measle; Vaccination

Online: 8 Feb 2010

DOI: http://dx.doi.org/10.3329/bmrcb.v35i3.4204

Bangladesh Med Res Counc Bull 2009; 35: 101-104

Downloads

Download data is not yet available.
Abstract
127
PDF
85

Downloads

Published

2010-02-08

How to Cite

Shilpi, T., Sattar, H., & Miah, M. R. A. (2010). Determining infants’ age for measles vaccination based on persistence of protective level of maternal measles antibody. Bangladesh Medical Research Council Bulletin, 35(3), 101–104. https://doi.org/10.3329/bmrcb.v35i3.4204

Issue

Vol. 35 No. 3 (2009)

Section

Research Papers

License

Authors who publish with this journal agree to the following terms.

Authors retain copyright and grant the journal right of first publication.

Creative Commons Licence
Articles in the Bangladesh Medical Research Council Bulletin are licensed under a Creative Commons Attribution 4.0 International License (CC-BY) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).